These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 15601662

  • 1. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.
    Diem R, Sättler MB, Merkler D, Demmer I, Maier K, Stadelmann C, Ehrenreich H, Bähr M.
    Brain; 2005 Feb; 128(Pt 2):375-85. PubMed ID: 15601662
    [Abstract] [Full Text] [Related]

  • 2. Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation.
    Maier K, Merkler D, Gerber J, Taheri N, Kuhnert AV, Williams SK, Neusch C, Bähr M, Diem R.
    Neurobiol Dis; 2007 Mar; 25(3):514-25. PubMed ID: 17239606
    [Abstract] [Full Text] [Related]

  • 3. HIV-Tat-mediated Bcl-XL delivery protects retinal ganglion cells during experimental autoimmune optic neuritis.
    Diem R, Taheri N, Dietz GP, Kuhnert A, Maier K, Sättler MB, Gadjanski I, Merkler D, Bähr M.
    Neurobiol Dis; 2005 Nov; 20(2):218-26. PubMed ID: 16242630
    [Abstract] [Full Text] [Related]

  • 4. Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study.
    Maier K, Kuhnert AV, Taheri N, Sättler MB, Storch MK, Williams SK, Bähr M, Diem R.
    Am J Pathol; 2006 Oct; 169(4):1353-64. PubMed ID: 17003491
    [Abstract] [Full Text] [Related]

  • 5. Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis.
    Sättler MB, Diem R, Merkler D, Demmer I, Boger I, Stadelmann C, Bähr M.
    Exp Neurol; 2005 May; 193(1):163-71. PubMed ID: 15817275
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis.
    Sättler MB, Merkler D, Maier K, Stadelmann C, Ehrenreich H, Bähr M, Diem R.
    Cell Death Differ; 2004 Dec; 11 Suppl 2():S181-92. PubMed ID: 15459752
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice.
    Guan Y, Shindler KS, Tabuena P, Rostami AM.
    J Neuroimmunol; 2006 Sep; 178(1-2):40-8. PubMed ID: 16828169
    [Abstract] [Full Text] [Related]

  • 11. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis.
    Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J.
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):681-91. PubMed ID: 17251466
    [Abstract] [Full Text] [Related]

  • 12. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF.
    Neuroimmunomodulation; 2008 Feb; 15(1):76-83. PubMed ID: 18667803
    [Abstract] [Full Text] [Related]

  • 13. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J, Ban EJ, Chun KH, Wang S, McQualter J, Bernard C, Toh BH, Alderuccio F.
    Autoimmunity; 2008 Aug; 41(5):405-13. PubMed ID: 18568646
    [Abstract] [Full Text] [Related]

  • 14. Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53.
    Herold S, Kumar P, Wichert SP, Kretzschmar B, Bähr M, Rossner MJ, Hein K.
    PLoS One; 2015 Aug; 10(10):e0138852. PubMed ID: 26426258
    [Abstract] [Full Text] [Related]

  • 15. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM, Desai S, Agasing A, Georgescu C, Wren JD, Axtell RC, Plafker SM.
    Mol Vis; 2016 Aug; 22():1503-1513. PubMed ID: 28050123
    [Abstract] [Full Text] [Related]

  • 16. Effect of geranylgeranylacetone on optic neuritis in experimental autoimmune encephalomyelitis.
    Guo X, Harada C, Namekata K, Kikushima K, Mitamura Y, Yoshida H, Matsumoto Y, Harada T.
    Neurosci Lett; 2009 Oct 25; 462(3):281-5. PubMed ID: 19616065
    [Abstract] [Full Text] [Related]

  • 17. N-methyl-D-aspartate receptor blockade is neuroprotective in experimental autoimmune optic neuritis.
    Sühs KW, Fairless R, Williams SK, Heine K, Cavalié A, Diem R.
    J Neuropathol Exp Neurol; 2014 Jun 25; 73(6):507-18. PubMed ID: 24806299
    [Abstract] [Full Text] [Related]

  • 18. Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions.
    Sättler MB, Demmer I, Williams SK, Maier K, Merkler D, Gadjanski I, Stadelmann C, Bähr M, Diem R.
    Exp Neurol; 2006 Sep 25; 201(1):172-81. PubMed ID: 16764858
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
    Kanwar JR, Kanwar RK, Krissansen GW.
    Brain; 2004 Jun 25; 127(Pt 6):1313-31. PubMed ID: 15130951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.